OXFORD NANOPORE TECHNOLOGIES GBP0.0001 overview

​Apple showcases Oxford Nanopore in M3 silicon chip launch OXFORD, UK / ACCESSWIRE / October 31, 2023 / Oxford Nanopore Technologies plc (LSE:ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, was showcased in Apple Inc.'s global product launch on Monday. Apple positioned Oxford Nanopore's DNA/RNA sequencing technology as a companion platform that can run on Apple devices equipped with its new M3 silicon chips, supporting broad...

Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market PR Newswire MINNEAPOLIS, Dec. 1, 2022 New collaboration will develop assays that offer a streamlined workflow for analysing even the most challenging genes. MINNEAPOLIS , Dec. 1, 2022 /PRNewswire/ -- Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), today announce a collaboration to develop assays...

Oxford Nanopore integrates "Remora": a tool to enable real-time, high-accuracy epigenetic insights with nanopore sequencing software MinKNOW Oxford Nanopore has today released Remora, a high-performance tool for methylation analysis, into its operating software, MinKNOW, broadening access to direct, PCR-free nanopore sequencing that captures methylation across the whole genome OXFORD, UK / ACCESSWIRE / May 26, 2022 / From today, Oxford Nanopore users have easy access to precise whole genome...

Oxford Nanopore delivers technology update at annual London Calling conference: bringing together years of innovation to showcase one sensing platform for all biological analyses OXFORD, UK / ACCESSWIRE / May 20, 2022 / At the annual London Calling conference, CTO Clive Brown and colleagues James Clarke, Stuart Reid, Lakmal Jayasinghe and Rosemary Sinclair Dokos have provided an Oxford Nanopore tech update summarising the status of its nanopore sensing platform, key recent developments that...

Oxford Nanopore's London Calling conference opens; amongst a breadth of ground-breaking research, increasing attention on human and cancer genomics Conference presentations set to highlight the utility of comprehensive genomic analysis using nanopore sequencing for novel discoveries in human genetics, cancer research, conservation, pathogen genomics and more OXFORD, UK / ACCESSWIRE / May 19, 2022 / The annual London Calling genomics conference, hosted by Oxford Nanopore, starts today, featuring...

Oxford Nanopore sequencing selected to generate comprehensive insights by characterising a more complete genome using samples from the 1000 Genomes Project Oxford Nanopore technology will enable the 1000 Genomes Project, spearheaded by researchers at the University of Washington and Seattle Children's Hospital, to gain greater genomic insights into clinically relevant variants by providing accurate, affordable, scalable and comprehensive information Uncovering new discoveries across the genome...

Genomics England expands use of Oxford Nanopore sequencing in cancer Oxford Nanopore technology will be used by Genomics England to investigate and validate at increasing scale the benefits of sequencing for improving patient care and advancing research to develop new treatments. Genomics England's "Long-Read Sequencing Programme" takes advantage of Oxford Nanopore's ability to sequence any-length fragments of DNA, including long and ultra-long OXFORD, UK / ACCESSWIRE / April 4, 2022 / Oxford...

Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluations Clive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates during a webinar today. Highlights include performance and base modification calling improvements, as well as updates on the recently-released Short Fragment Mode (SFM) and a new basecaller OXFORD, UK / ACCESSWIRE...